Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Bamia

Showing results (21-30 of 133) with videos related to

Pageof 14
Sort By:
European Journal of Nutrition|May 5, 2011
Identification of change-points in the relationship between food groups in the Mediterranean diet and overall mortality: an 'a posteriori' approachFrancesco Sofi, Rosanna Abbate, Gian Franco Gensini, et al.
Archives of Internal Medicine|April 30, 2008
Genetic predisposition, nongenetic risk factors, and coronary infarctAntonia Trichopoulou, Nikos Yiannakouris, Christina Bamia, et al.
Breast (Edinburgh, Scotland)|February 20, 2019
Physical activity in breast cancer survivors: A systematic review and meta-analysis on overall and breast cancer survivalMaria-Eleni Spei, Evangelia Samoli, Francesca Bravi, et al.
The British Journal of Nutrition|June 25, 2005
Comparison of two statistical approaches to predict all-cause mortality by dietary patterns in German elderly subjectsKurt Hoffmann, Heiner Boeing, Paolo Boffetta, et al.
Blood|July 23, 2016
DNA repair of myeloma plasma cells correlates with clinical outcome: the effect of the nonhomologous end-joining inhibitor SCR7Maria Gkotzamanidou, Evangelos Terpos, Christina Bamia, et al.
Haematologica|June 8, 2006
Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acidMeletios A Dimopoulos, Efstathios Kastritis, Athanasios Anagnostopoulos, et al.
Haematologica|November 21, 2007
Melphalan-induced DNA damage in vitro as a predictor for clinical outcome in multiple myelomaMeletios A Dimopoulos, Vassilis L Souliotis, Athanasios Anagnostopoulos, et al.
Oncology|January 18, 2012
A risk-adapted strategy of adjuvant paclitaxel/carboplatin in early-stage ovarian cancer: time-dependent effect of 4 versus 6 cycles on outcomeAristotle Bamias, Christina Bamia, Alexandra Karadimou, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2009
Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infectionsGeorge L Daikos, Panayiotis Petrikkos, Mina Psichogiou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factorsAristotle Bamias, Efstathios Kastritis, Christina Bamia, et al.
Pageof 14

Showing results (21-30 of 133) with videos related to

Sort By:
Pageof 14
European Journal of Nutrition|May 5, 2011
Identification of change-points in the relationship between food groups in the Mediterranean diet and overall mortality: an 'a posteriori' approachFrancesco Sofi, Rosanna Abbate, Gian Franco Gensini, et al.
Archives of Internal Medicine|April 30, 2008
Genetic predisposition, nongenetic risk factors, and coronary infarctAntonia Trichopoulou, Nikos Yiannakouris, Christina Bamia, et al.
Breast (Edinburgh, Scotland)|February 20, 2019
Physical activity in breast cancer survivors: A systematic review and meta-analysis on overall and breast cancer survivalMaria-Eleni Spei, Evangelia Samoli, Francesca Bravi, et al.
The British Journal of Nutrition|June 25, 2005
Comparison of two statistical approaches to predict all-cause mortality by dietary patterns in German elderly subjectsKurt Hoffmann, Heiner Boeing, Paolo Boffetta, et al.
Blood|July 23, 2016
DNA repair of myeloma plasma cells correlates with clinical outcome: the effect of the nonhomologous end-joining inhibitor SCR7Maria Gkotzamanidou, Evangelos Terpos, Christina Bamia, et al.
Haematologica|June 8, 2006
Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acidMeletios A Dimopoulos, Efstathios Kastritis, Athanasios Anagnostopoulos, et al.
Haematologica|November 21, 2007
Melphalan-induced DNA damage in vitro as a predictor for clinical outcome in multiple myelomaMeletios A Dimopoulos, Vassilis L Souliotis, Athanasios Anagnostopoulos, et al.
Oncology|January 18, 2012
A risk-adapted strategy of adjuvant paclitaxel/carboplatin in early-stage ovarian cancer: time-dependent effect of 4 versus 6 cycles on outcomeAristotle Bamias, Christina Bamia, Alexandra Karadimou, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2009
Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infectionsGeorge L Daikos, Panayiotis Petrikkos, Mina Psichogiou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factorsAristotle Bamias, Efstathios Kastritis, Christina Bamia, et al.
Pageof 14